Search
for
Sort by
Research 241–270 of 1000+
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib
- Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib
- Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Spotlight in Plastic Surgery: October 2022
- The Sebaceous Gland - Friend or Foe?
- 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- JAK-inhibitors in dermatology: current evidence and future applications
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- A review of Janus kinase inhibitor use in scarring alopecia
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Efficacy and safety of JAK inhibitors in treating lichen planopilaris or frontal fibrosing alopecia
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Trachyonychia secondary to pediatric alopecia areata responding to oral tofacitinib therapy: a case report and review of literature
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- The JAK/STAT signaling pathway: from bench to clinic
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Under Development JAK Inhibitors for Dermatologic Diseases
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology